SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001600132-19-000056
Filing Date
2019-03-14
Accepted
2019-03-14 08:23:15
Documents
71
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K blph-12312018x10k.htm 10-K 2067077
2 EXHIBIT 23.1 blph-12312018x10kex231.htm EX-23.1 4433
3 EXHIBIT 31.1 blph-12312018x10kex311.htm EX-31.1 11974
4 EXHIBIT 31.2 blph-12312018x10kex312.htm EX-31.2 11979
5 EXHIBIT 32 blph-12312018x10kex32.htm EX-32 7965
12 indicationtablea16.jpg GRAPHIC 44215
  Complete submission text file 0001600132-19-000056.txt   7592030

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT blph-20181231.xml EX-101.INS 1531754
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blph-20181231.xsd EX-101.SCH 47247
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT blph-20181231_cal.xml EX-101.CAL 74544
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT blph-20181231_def.xml EX-101.DEF 219461
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blph-20181231_lab.xml EX-101.LAB 632755
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blph-20181231_pre.xml EX-101.PRE 381519
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36845 | Film No.: 19679781
SIC: 2834 Pharmaceutical Preparations